Protagenic Therapeutics . Common Stock Stock Forecast

Sell candidate since Jul 02, 2026 Loss -13.04%

The Protagenic Therapeutics, Inc. Common stock price fell by -13.04% on the last day (Tuesday, 7th Jul 2026) from $0.230 to $0.200. During the last trading day the stock fluctuated 10.00% from a day low at $0.200 to a day high of $0.220. The price has been going up and down for this period, and there has been a -55.56% loss for the last 2 weeks. Volume has increased on the last day by 8 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 8 thousand shares were bought and sold for approximately $1.64 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.176 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -36.85% during the next 3 months and, with a 90% probability hold a price between $0.111 and $0.453 at the end of this 3-month period.

PTIX Signals & Forecast

There are few to no technical positive signals at the moment. The Protagenic Therapeutics, Inc. Common stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.303 and $0.464. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 11, 2026, and so far it has fallen -70.59%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Protagenic Therapeutics, Inc. Common gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Protagenic Therapeutics, Inc. Common stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0200 between high and low, or 10.00%. For the last week, the stock has had daily average volatility of 16.90%.

Protagenic Therapeutics, Inc. Common is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PTIX) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Protagenic Therapeutics, Inc. Common Stock to open at $0.207, and during the day (based on 14 day Average True Range), to move between $0.175 and $0.225, which gives a possible trading interval of +/-$0.0497 (+/-28.34%) up or down from last closing price. If Protagenic Therapeutics, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 28.34% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.230, some $0.0300 (15.00%) from the current price of $0.200, our system finds the risk reward not very attractive.

Is Protagenic Therapeutics, Inc. Common Stock stock A Buy?

Protagenic Therapeutics, Inc. Common holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -8.083 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 8, 2026 - $0.207 ( 3.33%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk